In a preclinical model, the blockage of CSF-1R signaling in glioma-bearing mice by using the anti-CSF-1R antibody Pexidartinib (PLX3397) resulted in a significantly reduced tumor infiltration of GAMs [112]. The gene discussed is CSF1R; the disease is neoplasm.